1. United States
2. Iowa
3. Letter

The FDA's decision to severely restrict access to the newly approved Novavax COVID-19 vaccine is deeply concerning. By limiting availability only to older adults and those with high-risk medical conditions, healthy individuals who may need the vaccine to protect immunocompromised loved ones or in preparation for future variants are left vulnerable. This contradicts the fundamental purpose of widespread vaccination – safeguarding not just individual health but also achieving community-wide protection. Infectious disease experts have criticized this move, highlighting the lack of scientific justification for such stringent limitations. Dr. Camille Kotton aptly described it as "a dark day in American medicine." Vaccines should be accessible to all who require them, not just a select few deemed high-risk by narrow criteria. I urge you to advocate for expanding eligibility for the Novavax vaccine and future COVID-19 vaccines. Widespread access is crucial for controlling the ongoing pandemic and preparing for potential future outbreaks. Restricting vaccines undermines public health efforts and leaves many unnecessarily exposed. Please prioritize equitable vaccine distribution guided by scientific evidence rather than ideological considerations.